Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVORY2: Immune Response to Yellow Fever Vaccination
NCT06718127Recruiting
- Sponsor
- Institut Pasteur
- Start
- Sep 2024
- Primary completion
- Apr 2026
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Open-label, single-arm trial of 17D yellow fever vaccine in yellow fever, sponsored by Institut Pasteur. Primary endpoint: Immunological profile of PBMCs, before and after yellow fever vaccination at 6 months. Started Sep 2024; status: recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT06718127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06718127.